Added to YB: 2023-10-31
Pitch date: 2023-10-31
LIAN [bullish]
LianBio
+371.77%
current return
Author Info
No bio for this author
Upgrade to Yellowbrick Premium to unlock investor returns. Upgrade to Yellowbrick Premium
Company Info
LianBio, a biopharmaceutical company, engages in developing and commercializing medicines for cardiovascular, oncology, opthalmology, and inflammatory diseases in China and other Asian countries.
Market Cap
$21.6M
Pitch Price
$0.02
Price Target
N/A
Dividend
N/A
EV/EBITDA
1.89
P/E
-0.24
EV/Sales
N/A
Sector
Biotechnology
Category
N/A
Show full summary:
LIANBIO -ADS LIAN
A summary for this pitch has not been created yet.
Read full article (0 min)